BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10829040)

  • 1. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.
    Dawson LA; McGinn CJ; Normolle D; Ten Haken RK; Walker S; Ensminger W; Lawrence TS
    J Clin Oncol; 2000 Jun; 18(11):2210-8. PubMed ID: 10829040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.
    Robertson JM; Lawrence TS; Andrews JC; Walker S; Kessler ML; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):325-30. PubMed ID: 9069303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
    Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.
    Robertson JM; Lawrence TS; Walker S; Kessler ML; Andrews JC; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):445-50. PubMed ID: 7751185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer.
    Lawrence TS; Kessler ML; Robertson JM
    Oncology (Williston Park); 1993 Oct; 7(10):51-7; discussion 57-8, 63. PubMed ID: 8251308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.
    Robertson JM; Lawrence TS; Dworzanin LM; Andrews JC; Walker S; Kessler ML; DuRoss DJ; Ensminger WD
    J Clin Oncol; 1993 Jul; 11(7):1286-93. PubMed ID: 8391066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma.
    Chen SW; Lin LC; Kuo YC; Liang JA; Kuo CC; Chiou JF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1041-7. PubMed ID: 24661657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.
    Shilkrut M; Sapir E; Hanasoge S; Schipper MJ; Normolle DP; Ben-Josef E; Ensminger W; Lawrence TS; Feng M
    Am J Clin Oncol; 2018 Apr; 41(4):326-331. PubMed ID: 26886946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I clinical trial of oral furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers, including clinicopathologic study.
    Zeng ZC; Tang ZY; Wu ZQ; Ma ZC; Fan J; Qin LX; Zhou J; Wang JH; Wang BL; Zhong CS
    Am J Clin Oncol; 2000 Oct; 23(5):449-54. PubMed ID: 11039502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective phase 2 multicenter study for the efficacy of radiation therapy following incomplete transarterial chemoembolization in unresectable hepatocellular carcinoma.
    Choi C; Koom WS; Kim TH; Yoon SM; Kim JH; Lee HS; Nam TK; Seong J
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1051-60. PubMed ID: 25303890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer.
    Kemeny N; Cohen A; Seiter K; Conti JA; Sigurdson ER; Tao Y; Niedzwiecki D; Botet J; Budd A
    J Clin Oncol; 1993 Feb; 11(2):330-5. PubMed ID: 8426211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
    Krishnan S; Lin EH; Gunn GB; Chandra A; Beddar AS; Briere TM; Das P; Delclos ME; Janjan NA; Crane CH
    Am J Clin Oncol; 2006 Dec; 29(6):562-7. PubMed ID: 17148992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?
    Koom WS; Seong J; Han KH; Lee DY; Lee JT
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1433-40. PubMed ID: 19896779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: efficacy and outcomes.
    Tanaka Y; Nakazawa T; Komori S; Hidaka H; Okuwaki Y; Takada J; Watanabe M; Shibuya A; Minamino T; Yamamoto H; Kokubu S; Hayakawa K; Koizumi W
    J Gastroenterol Hepatol; 2014 Feb; 29(2):352-7. PubMed ID: 23869689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver.
    O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE
    J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local radiotherapy for patients with unresectable hepatocellular carcinoma.
    Park W; Lim DH; Paik SW; Koh KC; Choi MS; Park CK; Yoo BC; Lee JE; Kang MK; Park YJ; Nam HR; Ahn YC; Huh SJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1143-50. PubMed ID: 15752895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer.
    Mohiuddin M; Chen E; Ahmad N
    J Clin Oncol; 1996 Mar; 14(3):722-8. PubMed ID: 8622017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.